A collection of news and information related to Avandia (drug) published by this site and its partners.
Displaying items 1-12 of 17 » View wsbtradio.com items only1 2 Next >
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...
Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...
Tags: Laws, Trials, Lawyers, Actos (drug), Yasmin (drug)
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlementAssistant Press SecretaryAttorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
ReutersWASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
Booster ShotsSulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
Los Angeles TimesThe diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...
Staff WriterThe arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
May 8, 2013 |Story| Reuters
Mar 25, 2013 |Story| Los Angeles Times
Feb 20, 2013 |Story| Baltimore Sun
Aug 1, 2012 |Story| Chicago Tribune
Jul 2, 2012 |Story| WPMT-LTV
Jul 2, 2012 |Story| Los Angeles Times
Feb 7, 2011 |Story| Reuters
Sep 24, 2010 |Resource Link| Health Portal
Dec 4, 2009 | Los Angeles Times
Jun 29, 2010 |Story| Los Angeles Times
Jul 13, 2010 |Story| Los Angeles Times
Jun 30, 2010 |Story| Health Portal
Original site for Avandia (drug) topic gallery.